MedPath

Chest closure without drainage after open patent ductus arteriosus ligation in Ugandan children. Open label randomized controlled trial.

Not Applicable
Conditions
Patent ductus arteriosus
Registration Number
PACTR201207000395469
Lead Sponsor
MEPI CVD linked project
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
86
Inclusion Criteria

All patients with a confirmed diagnosis of patent ductus arteriosus aged 12 years and below and whose guardians have consented

Exclusion Criteria

History of bronchospasm or found to have bronchospasms during pre-operative assessment.
Other combined chest surgery taking place at the time of PDA ligation.
Intraoperative damage to thoracic duct or Ductus Arteriosus

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The combined primary endpoint constituted the following complications; significant pleural space accumulation (pleural separation >30mm) at 48 hours post operatively or need for increased postoperative oxygen supplementation (>1L/min) or drainage site infection (seen as purulent discharge at the tube drain site).
Secondary Outcome Measures
NameTimeMethod
ICU stay beyond 24 hours from the time of post-operative admission.
© Copyright 2025. All Rights Reserved by MedPath